Posts tagged “UNC-CH”
3rdTech Quickly Generates $1 Million in Sales From Three UNC Technologies
Chapel Hill firm builds startups around university-licensed research. Trio of initial companies serve industrial design, forensic analysis and nanotech markets, and a fourth is in development.
Elan To Triple Georgia Drug Plant's Size, Add 100 Workers
The Irish pharmaceutical firm now makes 2 will drugs at the plant and will make 2 more. <b>Other news:</b> Nobex working with Pharmacia, Hamner honored.
Charlotte's Power Spots: Where the Deal Makers Go To Do Business
<b> New LTW Series: Hot Spots </b>Charlotte's tech industry deals aren't just done downtown. South End, Ballantyne, Southpark and University City draw entrepreneurs and financiers, too.
With CEO in Place, Oriel Therapeutics Goes After Dry Power Inhaler Market
Former GSK exec Paul Atkins to spearhead drive for $5 million in venture capital to back a "smart inhaler". UNC-CH spin-out already has raised $1 million.
Cary Custom Software Developer Makes Acquisition, Plans To Expand in 2002
Providence Software, which numbers SAP among its clients, acquires assets of Colorado firm. <b> Other software news: </b> BuildLinks expands; new deal for SAS
Ready for a Return to Growth? UNC Economist Sees Very Good Times Ahead
James Smith, professor of finance at UNC-CH and rated the most accurate economic forecaster three of the past five years by the Wall Street Journal, sees 10 years of strong growth ahead.
What Is Next Step in Keeping NC a Biotech Leader? The Debate Is On
Finding one big biotech project that brings together resources from across North Carolina may be the way to connect all parts of the State in efforts to add depth to its position as a biotech leader. So say observers from RTP and Charlotte.
Bridging the Gap Between Charlotte and RTP?
Can Charlotte, RTP, other parts of NC find common ground to help state succeed as a biotech leader? UNC-Charlotte, bolstered recently by a $2.25 million NIH grant, intends to be a player on its own.
Biotechnology Revolution Is Underway, and Several NC Firms Are in the Vanguard
These advances will change our lives more dramatically than the Internet ever did or ever will. A decade of miraculous discovery is ahead.
DarPharma Closes $3.2 Million First Round in Pursuit of Drugs To Fight Parkinson's
Chapel Hill-Greensboro start-up gets funding from angel investors and an $850,000 SBIR grant to develop its first-of-kind treatment for Parkinson's and other brain and nervous system disorders.
Scientists Must Address People's Ethical and Moral Concerns as Well as Desire for New Drugs, Experts
'Just because you're pursuing good science doesn't guarantee acceptance,' NCSU professor warns at Emerging Issues Forum. NC Biotech president calls for 'investment" in dealing with public's worries up front.
Franklin Street's Bill Moore Brings Vast Set of Financial Skills to MCNC Management Role
The technology research center is put in hands of a financial, business expert for the next several months. Search for permanent president to continue.
Bill Moore Brings Vast Set of Financial Skills to MCNC Management Role
The technology research center is put in hands of a financial, business expert for the next several months. Search for permanent president to continue.
$10 Million Gift - Charlotte Institute of Technology Innovation Fueled by Duke Energy
UNCC to use $10 million to establish a fund to help university make even bigger name for itself in the technology community. Gift is largest given by Duke Energy Foundation
Powerful BioGrid Could Give a Huge Boost to North Carolina's Genomics Effort
Can NC keep its lead as a center for genomics and bioinformatics research? The NC Genomics and Bioinformatics Consortium explains its first project aimed at doing just that - an advanced computing network called the NC Bioinformatics Grid.
E-mail Preferences
![[VIDEO]](http://wwwcache.wral.com/asset/business/2012/05/15/11105443/11105444-1337269517-80x60.jpg)
Could Facebook cue tech bubble?
![[VIDEO]](http://wwwcache.wral.com/asset/business/2012/05/15/11105443/11105445-1337253686-80x60.jpg)
Facebook 101: Examining a…
![[VIDEO]](http://wwwcache.wral.com/asset/business/2012/05/14/11100576/265788-facebook-80x60.jpg)
Buffett won't join Facebook IPO mania
![[VIDEO]](http://wwwcache.wral.com/presentation/v2/images/1x1.gif "http://wwwcache.wral.com/asset/business/2012/05/11/11091792/11091793-1336751325-80x60.jpg")
Japan's tech titans post record losses
FBI study reveals cyber crime trends
Community collaborates for Triangle Wiki
Video game conference is strictly…
Re-program speed dial before Saturday
Red Hat exec talks about company's $1B…
MedCity
- Wireless energy cardiac implant technology “gamechanger” in Penn State licensing deal
- Hepatitis C, liver cancer research at UNC secures $2.3M federal grant
- Minimally invasive spinal product firm raises $25 million in Series C round
- HGSI thwarts GSK takeover with poison pill, buys time to seek other offers
- New partnership could boost CoverMyMeds’ health insurance customer base